BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  beta: 1244, 2: 13800     

HTML
100%
Crohn's disease: beyond antagonists of tumour necrosis factor
Bamias G, Nyce MR, De La Rue SA, Cominelli F.

New concepts in the pathophysiology of inflammatory bowel disease.

Ann Intern Med 2005; 143: 895-904.

Baumgart DC, Carding SR.

Inflammatory bowel disease: cause and immunobiology.

Lancet:  Jul 4 2008 12:44AM
Matching: beta 2
Find similar documents
HTML
100%
Conventional wisdom on race-based disparities in heart-failure care challenged
Chicago, IL - African Americans treated in the hospital for acute decompensated heart failure (ADHF), compared with whites, are more likely to have several important cardiovascular risk indicators and in other ways appear to have heart...
Theheart.org:  Jul 4 2008 3:27AM
Matching: beta 2
Find similar documents
HTML
100%
Letting the genome out of the bottle: Unraveling the genetics of heart disease
London, UK - At the AHA Scientific Sessions in Orlando last November, deCODE Genetics offered its test for 9p21a variant that is recognized to be the strongest genetic predictor of early MI discovered to date [1,2,3]retailing at around $200,...
Theheart.org:  Jul 3 2008 10:43AM
Matching: beta 2
Find similar documents
HTML
100%
New finding may pave way for improved diabetes treatment
Washington, July 2 : A new study is shedding light on processes that determine the release of the blood sugar-lowering hormone insulin, thereby acting as a potential target for developing improved diabetes treatment.

Cyclic AMP (cAMP...

NewKerala.com:  Jul 3 2008 7:58PM
Matching: beta 2
Find similar documents
HTML
100%
Hint that ARBs are beneficial in Marfan's syndrome
Baltimore, MD - Use of angiotensin-2-receptor blockers (ARBs) has slowed the rate of progressive aortic root dilation in a small study of patients with Marfan's syndrome [1].

Dr Benjamin S Brooke (Johns Hopkins University School of...

Theheart.org:  Jul 3 2008 6:08AM
Matching: beta 2
Find similar documents
HTML
100%
Group A Streptococcus vaccines: considering the issues
ExpertREACT.

The highly successful XVII Lancefield conference recently held in Porto Heli, Greece brought together experts in Streptococcal diseases from around the globe.

The proceedings continued to remind us of the need for vaccine to...

PharmiWeb:  Jul 3 2008 2:01PM
Matching: beta 2
Find similar documents
HTML
100%
Key Variables Forecast Success of IVF
STANFORD, Calif., July 2 -- A new technique was 70% accurate in predicting whether a woman undergoing in vitro fertilization treatment would become pregnant, researchers here found.

Taken together, four variables -- the total number...

MedPage Today:  Jul 2 2008 10:40PM
Matching: beta 2
Find similar documents
HTML
100%
Watermelon May Have Viagra Effect
The big juicy fruit may increase libido, researchers find A cold slice of watermelon has long been a Fourth of July holiday staple.

But according to recent studies, the juicy fruit may be better suited to Valentine's Day.

Scientists say...

Consumer Affairs:  Jul 3 2008 8:11PM
Matching: beta 2
Find similar documents
HTML
100%
Low HDL-C associated with poor memory
Villejuif Cedex, France - A low level of HDL cholesterol in middle age is associated with poor memory and could lead to dementia later in life, a new study suggests [1].

The study, published in the July 1, 2008 issue of Arteriosclerosis,...

Theheart.org:  Jul 3 2008 6:07AM
Matching: beta 2
Find similar documents
HTML
100%
Automated Metabolite Identification System
MetaboLynx (v3.4) is a breakthrough in Mass-Informatics enabling automated detection and identification of drug metabolites - targeted Details MetaboLynx (v3.4) is a breakthrough in Mass-Informatics enabling automated detection and...
Drug Discovery Online:  Jul 3 2008 3:57AM
Matching: beta 2
Find similar documents
HTML
69%
Beta-blockers Underdosed in Veterans with Heart Failure
NEW YORK (Reuters Health) - Among predominantly elderly veterans with heart failure, most are prescribed doses of carvedilol or controlled-release metoprolol that are well below the proven effective dose, according to study findings...
Therapeutics Daily:  Jul 3 2008 7:43PM
Matching: beta
Find similar documents
HTML
69%
Now They Tell Me Watermellon is Natures Viagra
For years I may have been slowly killing myself following my doctors advice not to eat butter, but instead switching to trans fat laden margarine.

Why is it he could not inform me of the earth shaking news that watermelon is nature's...

Associated Content:  Jul 3 2008 9:14PM
Matching: beta
Find similar documents
HTML
69%
Novel classification scheme for coronary anomaly can guide therapy
Novel classification scheme for coronary anomaly can guide therapyJuly 3, 2008 Los Angeles, CA and Galveston, TX - A large series of symptomatic patients without angiographic CAD but found to have myocardial bridging, a common coronary...
Theheart.org:  Jul 3 2008 7:03PM
Matching: beta
Find similar documents
HTML
69%
TopAbstracts in Bladder Cancer 07/02/2008
TopAbstracts in Bladder Cancer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days.

Over 2000 peer-reviewed...

Doctors Guide:  Jul 3 2008 4:38PM
Matching: beta
Find similar documents
HTML
69%
SOLVO is the exclusive commercial provider of B-CLEAR kits and a provider of B-CLEAR services in Europe
June 13th 2008: Qualyst, Inc.s patented B-CLEAR sandwich-cultured hepatocyte technology is the only in vitro method which can evaluate hepatobiliary disposition of a compound, predict in vivo hepatic uptake and biliary clearance, and assess...
BioPortfolio:  Jul 3 2008 2:58PM
Matching: beta
Find similar documents
HTML
69%
New finding may pave way for improved diabetes treatment
A new study is shedding light on processes that determine the release of the blood sugar-lowering hormone insulin, thereby acting as a potential target for developing improved diabetes treatment.

Cyclic AMP (cAMP) is a universal messenger...

NetIndia123.com:  Jul 3 2008 6:20AM
Matching: beta
Find similar documents
HTML
69%
New finding paves way for improved diabetes treatment
A new study is shedding light on processes that determine the release of the blood sugar-lowering hormone insulin, thereby acting as a potential target for developing improved diabetes treatment.

Cyclic AMP (cAMP) is a universal messenger...

ZeeNews.com:  Jul 3 2008 12:55PM
Matching: beta
Find similar documents
HTML
69%
Post-MI angina common, underappreciated, undertreated in registry study
Chicago, IL - One in five patients with an MI experienced angina one year after hospitalization for the acute event, and a substantial minority of those with angina had symptoms at least weekly, in a prospective, multicenter registry...
Theheart.org:  Jul 3 2008 6:35AM
Matching: beta
Find similar documents
HTML
69%
ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimer's at ICAD 2008
PARIS On this occasion, ExonHit will reveal several posters and participate in an oral presentation, entitled 'EHT 0202: A Neuroprotective And Procognitive Alpha-secretase Stimulator Targeted Towards Alzheimer Disease Therapy', lead by...
Rehab Manegement:  Jul 3 2008 12:01AM
Matching: beta
Find similar documents
HTML
100%
Low HDL Cholesterol Is a Risk Factor for Deficit and Decline in Memory in Midlife. The Whitehall II Study
From INSERM u687-IFR69, the Department of Epidemiology and Public Health (A.S.-M., D.G., M.K., E.B., M.G.M.), University College London, UK; and the Centre de Gerontologie, Hopital Ste Perine (A.S.-M.), AP-HP, France.

'The National...

National AIDS Treatment Advocacy Project:  Jul 2 2008 6:03AM
Matching: beta 2
Find similar documents
HTML
100%
New discovery a step towards better diabetes treatment
The discovery is based on the development of image analysis methods that make possible the detailed study of events immediately inside the plasma membrane of the insulin-secreting cells.

Cyclic AMP (cAMP) is a universal messenger molecule...

Huliq.com:  Jul 2 2008 12:51PM
Matching: beta 2
Find similar documents
HTML
100%
Comprehensive Evaluation of Pharmaceutical Wholesalers and Distributors in the UK
DUBLIN, Ireland - (Business Wire) Research and Markets (http://www.researchandmarkets.com/research/249b33/pharmaceutical_who) has announced the addition of the 'Pharmaceutical Wholesalers & Distributors (UK) - Portfolio Analysis'...
Earthtimes.org:  Jul 2 2008 11:50AM
Matching: beta 2
Find similar documents
HTML
100%
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V
Cubist Pharmaceuticals, Inc.

(CBST) today announced that it has signed an exclusive agreement with AstraZeneca (AZN) to promote and provide other support in the United States for MERREM I.V.

(meropenem for injection), an established...

Houston Chronicle:  Jul 2 2008 10:49AM
Matching: beta 2
Find similar documents
HTML
100%
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V
Leverages Proven U.S.

Acute Care Sales Organization Complements Cubists Gram-Positive CUBICIN Company Website: http://www.cubist.com LEXINGTON, Mass.

-- (Business Wire) Cubist Pharmaceuticals, Inc.

(NASDAQ: CBST) today announced that...

Stockwatch:  Jul 2 2008 10:39AM
Matching: beta 2
Find similar documents
HTML
100%
New discovery a step towards better diabetes treatment
In the July 2nd issue of the prestigious journal Cell Metabolism Uppsala scientists are presenting new findings that shed light on the processes that determine the release of the blood sugar-lowering hormone insulin.

The discovery is based...

News-Medical.Net:  Jul 2 2008 12:45AM
Matching: beta 2
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.